[go: up one dir, main page]

FI20000403A0 - Use of GDNF family-related compounds for the preparation of testicular cancer treatment products - Google Patents

Use of GDNF family-related compounds for the preparation of testicular cancer treatment products

Info

Publication number
FI20000403A0
FI20000403A0 FI20000403A FI20000403A FI20000403A0 FI 20000403 A0 FI20000403 A0 FI 20000403A0 FI 20000403 A FI20000403 A FI 20000403A FI 20000403 A FI20000403 A FI 20000403A FI 20000403 A0 FI20000403 A0 FI 20000403A0
Authority
FI
Finland
Prior art keywords
preparation
cancer treatment
related compounds
testicular cancer
treatment products
Prior art date
Application number
FI20000403A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Hannu Sariola
Xiaojuan Meng
Mervi Hyvoenen
Maria Lindahl
Mart Saarma
Original Assignee
Hannu Sariola
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hannu Sariola filed Critical Hannu Sariola
Priority to FI20000403A priority Critical patent/FI20000403A0/en
Publication of FI20000403A0 publication Critical patent/FI20000403A0/en
Priority to PCT/FI2001/000173 priority patent/WO2001062273A1/en
Priority to AU2001240723A priority patent/AU2001240723A1/en

Links

FI20000403A 2000-02-22 2000-02-22 Use of GDNF family-related compounds for the preparation of testicular cancer treatment products FI20000403A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI20000403A FI20000403A0 (en) 2000-02-22 2000-02-22 Use of GDNF family-related compounds for the preparation of testicular cancer treatment products
PCT/FI2001/000173 WO2001062273A1 (en) 2000-02-22 2001-02-21 The use of gdnf family-related compounds for manufacturing products for treating testicular tumors
AU2001240723A AU2001240723A1 (en) 2000-02-22 2001-02-21 The use of gdnf family-related compounds for manufacturing products for treatingtesticular tumors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20000403A FI20000403A0 (en) 2000-02-22 2000-02-22 Use of GDNF family-related compounds for the preparation of testicular cancer treatment products

Publications (1)

Publication Number Publication Date
FI20000403A0 true FI20000403A0 (en) 2000-02-22

Family

ID=8557661

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20000403A FI20000403A0 (en) 2000-02-22 2000-02-22 Use of GDNF family-related compounds for the preparation of testicular cancer treatment products

Country Status (3)

Country Link
AU (1) AU2001240723A1 (en)
FI (1) FI20000403A0 (en)
WO (1) WO2001062273A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008201996B2 (en) * 2001-09-18 2011-02-10 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP2143438B1 (en) 2001-09-18 2011-07-13 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumors
SMT201900203T1 (en) 2010-05-20 2019-05-10 Array Biopharma Inc Macrocyclic compounds as trk kinase inhibitors
SI3322706T1 (en) 2015-07-16 2021-04-30 Array Biopharma, Inc. Substituted pyrazolo(1,5-a)pyridine compounds as ret kinase inhibitors
TWI704148B (en) 2016-10-10 2020-09-11 美商亞雷生物製藥股份有限公司 Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
JOP20190077A1 (en) 2016-10-10 2019-04-09 Array Biopharma Inc Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
CA3049136C (en) 2017-01-18 2022-06-14 Array Biopharma Inc. Substituted pyrazolo[1,5-a]pyrazine compounds as ret kinase inhibitors
WO2018136663A1 (en) 2017-01-18 2018-07-26 Array Biopharma, Inc. Ret inhibitors
JOP20190213A1 (en) 2017-03-16 2019-09-16 Array Biopharma Inc Macrocyclic compounds as ros1 kinase inhibitors
TWI791053B (en) 2017-10-10 2023-02-01 美商亞雷生物製藥股份有限公司 Crystalline forms of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile and pharmaceutical composition thereof
TWI876442B (en) 2017-10-10 2025-03-11 美商絡速藥業公司 Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
CN107827983B (en) * 2017-11-06 2020-09-25 中国药科大学 Targeting ARTN single-chain antibody, preparation method and application
EP3740491A1 (en) 2018-01-18 2020-11-25 Array Biopharma, Inc. Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors
JP6997876B2 (en) 2018-01-18 2022-02-04 アレイ バイオファーマ インコーポレイテッド Substituted pyrazolyl [4,3-C] pyridine compound as a RET kinase inhibitor
US11524963B2 (en) 2018-01-18 2022-12-13 Array Biopharma Inc. Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors
ES2922314T3 (en) 2018-09-10 2022-09-13 Array Biopharma Inc Fused Heterocyclic Compounds as RET Kinase Inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000501924A (en) * 1995-11-13 2000-02-22 イバネズ，カルロス Receptors for neuroglial factors derived from the glial cell line
US6428977B1 (en) * 1995-12-20 2002-08-06 Curis, Inc. Signalin family of TGFβ signal transduction proteins, and uses related thereto
US6692943B1 (en) * 1996-03-14 2004-02-17 Washington University Persephin and related growth factors
NZ509592A (en) * 1998-08-21 2003-01-31 Meng Xiaojuan The use of GLIAL cell line-derived neurotrophic factor familty-related compounds for regulating spermatogenesis and for preparing male contraceptives

Also Published As

Publication number Publication date
AU2001240723A1 (en) 2001-09-03
WO2001062273A1 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
FI20000403A0 (en) Use of GDNF family-related compounds for the preparation of testicular cancer treatment products
EE200300497A (en) Pyrazole derivatives for the treatment of HIV
AU6048201A (en) Quinazoline derivatives for the treatment of tumours
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
EE04747B1 (en) Process for the preparation of amine-platinum complexes
NO20030012L (en) Process for the preparation of substituted octanoylamides
NO20024775D0 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20030163L (en) Process for the preparation of olefins
IS6917A (en) Epothilone derivatives for the treatment of difficult tumors
DE60030554D1 (en) USES OF ET743 FOR THE TREATMENT OF CANCER
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
IL161059A0 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
EE05308B1 (en) Process for the preparation of sulfonamide-substituted imidazotriazinones
FR2798664B1 (en) PROCESS FOR THE PREPARATION OF MICROGELS OF CONTROLLED SIZE
NO20042640L (en) Process for the preparation of echinocandin derivatives
NO20024776L (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
NO20024777D0 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20035538D0 (en) Process for the preparation of zaleplon
SI1475379T1 (en) Use of skopin ester derivatives for the preparation of medicines
ATE374011T1 (en) SKIN TREATMENT PRODUCTS
EP1461030A4 (en) Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
NO20026155L (en) Process for the preparation of lower olefins
NO20030515L (en) Process for the preparation of dinapsoline
AU2001214116A1 (en) Novel paclitaxel derivatives for the treatment of cancer
PT1268482E (en) PIRANOINDOIS FOR THE TREATMENT OF GLAUCOMA